GILEAD SCIENCES, INC. Proceeds from Issuance of Debt
GILEAD SCIENCES, INC. (GILD) reported Proceeds from Issuance of Debt of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-22.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfDebt · last filed 2023-02-22
- GILEAD SCIENCES, INC. proceeds from issuance of debt for the quarter ending 2022-12-31 was $0.00.
- GILEAD SCIENCES, INC. proceeds from issuance of debt for the quarter ending 2022-09-30 was $0.00.
- GILEAD SCIENCES, INC. proceeds from issuance of debt for the quarter ending 2022-06-30 was $0.00.
- GILEAD SCIENCES, INC. proceeds from issuance of debt for the quarter ending 2022-03-31 was $0.00.
- GILEAD SCIENCES, INC. proceeds from issuance of debt for fiscal 2022 was $0.00.
- GILEAD SCIENCES, INC. proceeds from issuance of debt for fiscal 2021 was $0.00.
| Period end | Proceeds from Issuance of Debt 3 month | Proceeds from Issuance of Debt 6 month | Proceeds from Issuance of Debt 9 month | Proceeds from Issuance of Debt 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $0.00 derived: sum of 2 quarters · filed 2023-02-22 | $0.00 derived: sum of 3 quarters · filed 2023-02-22 | $0.00 10-K · filed 2023-02-22 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-02 | $0.00 derived: sum of 2 quarters · filed 2022-11-02 | $0.00 10-Q · filed 2022-11-02 | $0.00 derived: sum of 4 quarters · filed 2022-11-02 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-08 | $0.00 10-Q · filed 2022-08-08 | $0.00 derived: sum of 3 quarters · filed 2022-08-08 | $0.00 derived: sum of 4 quarters · filed 2022-08-08 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-04 | $0.00 derived: sum of 2 quarters · filed 2022-05-04 | $0.00 derived: sum of 3 quarters · filed 2022-05-04 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $0.00 derived: sum of 2 quarters · filed 2022-02-23 | $0.00 10-K · filed 2022-02-23 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-03 | $0.00 10-Q · filed 2021-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |